These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 12007467)
1. Phase-resolved fluorescence study of mono-L-aspartyl chlorin E6. Li L; Kodama K; Saito K; Aizawa K J Photochem Photobiol B; 2002 May; 67(1):51-6. PubMed ID: 12007467 [TBL] [Abstract][Full Text] [Related]
2. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors. Spikes JD; Bommer JC J Photochem Photobiol B; 1993 Feb; 17(2):135-43. PubMed ID: 8459317 [TBL] [Abstract][Full Text] [Related]
3. Transadventitial localisation of atheromatous plaques by fluorescence emission spectrum analysis of mono-L-aspartyl chlorin e6. Hayashi J; Kuroiwa Y; Sato H; Saito T; Aizawa K Cardiovasc Res; 1993 Nov; 27(11):1943-7. PubMed ID: 8287401 [TBL] [Abstract][Full Text] [Related]
4. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy. Wong TW; Aizawa K; Sheyhedin I; Wushur C; Kato H J Pharmacol Sci; 2003 Oct; 93(2):136-42. PubMed ID: 14578580 [TBL] [Abstract][Full Text] [Related]
5. Localization of experimental submucosal esophageal tumor in rabbits by using mono-L-aspartyl chlorin e6 and long-wavelength photodynamic excitation. Sheyhedin I; Okunaka T; Kato H; Yamamoto Y; Sakaniwa N; Konaka C; Aizawa K Lasers Surg Med; 2000; 26(1):83-9. PubMed ID: 10637007 [TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study. Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces. Chan AL; Juarez M; Allen R; Volz W; Albertson T Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. Taber SW; Fingar VH; Coots CT; Wieman TJ Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737 [TBL] [Abstract][Full Text] [Related]
9. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Ferrario A; Kessel D; Gomer CJ Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904 [TBL] [Abstract][Full Text] [Related]
10. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6]. Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6. Mori K; Yoneya S; Anzail K; Kabasawa S; Sodeyama T; Peyman GA; Moshfeghi DM Retina; 2001; 21(5):499-508. PubMed ID: 11642380 [TBL] [Abstract][Full Text] [Related]
12. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro. Sheyhedin I; Aizawa K; Araake M; Kumasaka H; Okunaka T; Kato H Photochem Photobiol; 1998 Jul; 68(1):110-4. PubMed ID: 9679456 [TBL] [Abstract][Full Text] [Related]
13. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model. Wong Kee Song LM; Wang KK; Zinsmeister AR Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202 [TBL] [Abstract][Full Text] [Related]
14. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Gomer CJ; Ferrario A Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446 [TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6. Katsumi TA; Aizawa K; Kuroiwa Y; Saito K; Kurata Y; Ii Y; Okunaka T; Konaka C; Kato H Photochem Photobiol; 1996 Oct; 64(4):671-5. PubMed ID: 8863472 [TBL] [Abstract][Full Text] [Related]
16. Photobleaching of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors. Spikes JD; Bommer JC Photochem Photobiol; 1993 Sep; 58(3):346-50. PubMed ID: 8234467 [TBL] [Abstract][Full Text] [Related]
17. Interactions between N-aspartyl chlorin e6, detergent micelles and plasma lipoproteins. Kessel D Photochem Photobiol; 1995 Jun; 61(6):646-9. PubMed ID: 7568411 [TBL] [Abstract][Full Text] [Related]
18. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries. Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521 [TBL] [Abstract][Full Text] [Related]
19. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines. Nakamura H; Suzuki Y; Takeichi M; Saito T; Takayama M; Aizawa K Int J Gynecol Cancer; 2002; 12(2):177-86. PubMed ID: 11975677 [TBL] [Abstract][Full Text] [Related]
20. Intraocular biodistribution of mono-L-aspartyl chlorin e6 in a primate choroidal neovascularization model. Mori K; Kanai K; Peyman GA; Yoneya S Ophthalmic Surg Lasers Imaging; 2007; 38(2):142-7. PubMed ID: 17396695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]